Baixar PDF
1
/
Páginas
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Is dyslipidemia a risk factor for trastuzumab-induced cardiotoxicity in breast cancer patients? A systematic review and meta-analysis
Jaime Pinho; Miguel Carvalho; Mariana Paiva; Nuno Teixeira-Tavares; Cristina Costa-Santos; Carla Sousa;
Rev Port Cardiol. 2023;42:961-84
The effect of paclitaxel plus carboplatin chemotherapy on subclinical cardiotoxicity in patients with non-small cell lung cancer: A speckle tracking echocardiography-based study
Batur Gonenc Kanar; Ak¿n Ozturk; Alper Kepez; Dursun Akaslan; Murat Kavas; Erhan Ogur; Kamil Gu¿ls¿en; Akyan Ku¿p; Bahar Dalk¿l¿c¿; Kursat Tigen; Beste Ozben;
Rev Port Cardiol. 2022;41:931-8
Irbesartan has a curative effect on lipopolysaccharide-induced cardiotoxicity by antioxidant and antiapoptotic pathways
Muhammet Yusuf Tepeba¿i; Halil A¿ci; Samet Co¿an; Mehmet Abdülkadir Sevük; Nas¿f Fatih Karakuyu; Özlem Özmen;
Rev Port Cardiol. 2023;42:895-903